The incidence of jaw osteonecrosis in multiple myeloma patients treated with bisphosphonates.
作者信息
Kraj Maria, Pogłód Ryszard, Maj Stanisław, Owczarska Katarzyna
机构信息
Department of Haematology Institute of Haematology and Blood Transfusion, ul. Chocimska 5, Warszawa, Poland.
出版信息
Acta Pol Pharm. 2006 Sep-Oct;63(5):450-2.
PMID:17357613
Abstract
摘要
相似文献
1
The incidence of jaw osteonecrosis in multiple myeloma patients treated with bisphosphonates.接受双膦酸盐治疗的多发性骨髓瘤患者颌骨坏死的发生率。
Acta Pol Pharm. 2006 Sep-Oct;63(5):450-2.
2
Why osteonecrosis of the jaw after bisphosphonates treatment is more frequent in multiple myeloma than in solid tumors.为什么双膦酸盐治疗后颌骨坏死在多发性骨髓瘤中比在实体瘤中更常见。
J Oral Maxillofac Surg. 2006 Jun;64(6):995-6. doi: 10.1016/j.joms.2006.03.002.
3
Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.双膦酸盐治疗后癌症患者颌骨骨坏死：发病率及危险因素
J Clin Oncol. 2005 Dec 1;23(34):8580-7. doi: 10.1200/JCO.2005.02.8670.
4
Recurrent low-energy femoral shaft fractures and osteonecrosis of the jaw in a case of multiple myeloma treated with bisphosphonates.一名接受双膦酸盐治疗的多发性骨髓瘤患者出现复发性低能量股骨干骨折和颌骨骨坏死。
J Oral Maxillofac Surg. 2009 Mar;67(3):645-9. doi: 10.1016/j.joms.2008.11.005.
5
Osteonecrosis of the jaws and bisphosphonates. Report of three cases.颌骨骨坏死与双膦酸盐。三例报告。
Med Oral Patol Oral Cir Bucal. 2006 Jan 1;11(1):E76-9.
6
Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases.与双膦酸盐相关的颌骨坏死：多个暴露区域及其与拔牙的关系。20例研究。
Oral Oncol. 2006 Mar;42(3):327-9. doi: 10.1016/j.oraloncology.2005.08.001. Epub 2005 Nov 4.
7
Bisphosphonate-induced osteonecrosis of the jaw: long-term outcomes.双膦酸盐类药物所致颌骨骨坏死：长期预后
J Support Oncol. 2009 Jan-Feb;7(1):9-10.
8
Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid.接受双膦酸盐治疗的多发性骨髓瘤患者的颌骨骨坏死：唑来膦酸治疗后风险增加的证据。
Haematologica. 2006 Jul;91(7):968-71. Epub 2006 Jun 1.
9
Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma.双膦酸盐相关颌骨坏死：一种治疗困境。
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Mar;103(3):e1-5. doi: 10.1016/j.tripleo.2006.09.022. Epub 2007 Jan 2.
10
A time for perspective on bisphosphonates.审视双膦酸盐类药物的时机。
J Oral Maxillofac Surg. 2006 Jun;64(6):877-9. doi: 10.1016/j.joms.2006.04.003.
引用本文的文献
1
State of oral mucosa as an additional symptom in the course of primary amyloidosis and multiple myeloma disease.口腔黏膜状态作为原发性淀粉样变性和多发性骨髓瘤病程中的一种附加症状。
Case Rep Med. 2014;2014:293063. doi: 10.1155/2014/293063. Epub 2014 Jun 9.
2
Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates.接受静脉注射双膦酸盐治疗的癌症患者颌骨坏死的发生率及相关危险因素。
J Bone Miner Res. 2008 Jun;23(6):826-36. doi: 10.1359/jbmr.080205.
Zotero 插件